Atlas Trials

Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)

Clinical trial NCT01939002 · COMPLETED

Trial details

NCT number
NCT01939002
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsing Multiple Sclerosis
Start date
2013-11-01
Primary completion
2015-10-01
Enrollment
251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.